Neurogene (NGNE) Non-Current Assets (2013 - 2026)

Neurogene (NGNE) posted Non-Current Assets of $16.4 million for Q1 2026, down 2.61% on a QoQ basis from $16.8 million in Q4 2025, and down 13.27% year-over-year from $18.9 million in Q1 2025.

Neurogene (NGNE) Non-Current Assets (2013 - 2026) Analysis & Trends

Neurogene's Non-Current Assets history runs 14 years deep, the most recent figure standing at $16.4 million for Q1 2026.

  • Quarterly Non-Current Assets fell 13.27% year-over-year to $16.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $68.9 million (down 13.76% YoY) and the FY2025 annual result came in at $16.8 million, down 15.01% from the prior year.
  • Non-Current Assets was $16.4 million for Q1 2026 at Neurogene, down from $16.8 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $24.5 million in Q4 2022 and bottomed at $9.7 million in Q3 2023.
  • A 5-year average of $17.9 million and a median of $18.5 million in 2022 frame the typical range for Non-Current Assets.
  • Annual changes were most pronounced in 2023 — Non-Current Assets slumped 45.3% — and 2024, when it jumped 111.21%.
  • Neurogene's Non-Current Assets stood at $24.5 million in 2022, then slipped by 9.46% to $22.2 million in 2023, then decreased by 10.88% to $19.8 million in 2024, then retreated by 15.01% to $16.8 million in 2025, then slipped by 2.61% to $16.4 million in 2026.
  • Business Quant data shows NGNE's Non-Current Assets at $16.4 million in Q1 2026, $16.8 million in Q4 2025, and $17.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 21.65 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 5.83 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.95 Bn
4 NuCana 279.75 Bn 279.75 Bn - 3.95 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 285.82 Mn
10 Neurogene 17.50 Mn 17.50 Mn - 16.39 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 16.39 Mn
Dec 31, 2025 16.83 Mn
Sep 30, 2025 17.31 Mn
Jun 30, 2025 18.33 Mn
Mar 31, 2025 18.90 Mn
Dec 31, 2024 19.81 Mn
Sep 30, 2024 20.47 Mn
Jun 30, 2024 20.67 Mn
Mar 31, 2024 21.21 Mn
Dec 31, 2023 22.23 Mn
Sep 30, 2023 9.69 Mn
Jun 30, 2023 10.23 Mn
Mar 31, 2023 12.82 Mn
Dec 31, 2022 24.55 Mn
Sep 30, 2022 17.72 Mn
Jun 30, 2022 18.54 Mn
Mar 31, 2022 18.76 Mn
Dec 31, 2021 19.27 Mn
Sep 30, 2021 19.44 Mn
Jun 30, 2021 19.53 Mn